That depends on what you mean by “goes after NSF.” If the arbitration agreement awards CYDY so much that Amarex can’t pay it, and tries to flee into bankruptcy, I can’t imagine that Sidley-Austin would not try to pierce the corporate veil and try to get NSF to pay the award for which their CONTROLLED subsidiary Amarex has liability.

I remind you also of the recent ruling, within the past few days, that Johnson & Johnson cannot escape liability in the injury class-action case, by spinning off the liability into a subsidiary and then having the subsidiary declare bankruptcy.